Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.97B |
| Enterprise Value | 11.53B |
| P/E Ratio | 23.73 |
| PEG Ratio | -0.93 |
| Price/Sales Ratio | 2.06 |
| Price/Book Ratio | 1.54 |
| Enterprise/Revenue | 1.6 |
| Enterprise/EBITDA | 12.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 6.4B |
| Revenue/Share | 122.64 |
| Gross Profit | 3.48B |
| EBITDA | 724M |
| Net Income | 923M |
| Diluted EPS | 18.37 |
Balance Sheet
| Total Cash | 3.83B |
| Total Cash/Share | 76.26 |
| Total Debt | 479M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.14 |
| Book Value Per Share | 164.53 |
Price History
| 52-Week Change | -10.6 |
| 52-Week High | 335 |
| 52-Week Low | 246 |
| Moving Average 50 Days | 264.22 |
| Moving Average 200 Days | 285.79 |
Statistics
| Average Volume | 107,283 |
| Shares Outstanding | 50.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.3 |
| Trailing Annual Dividend Yield | 1.3 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | March 30, 2020 |
AD
